Form 4: Ingredion CEO Exercises Options, Sells Shares

Ingredion's President and CEO, James P. Zallie, reported exercising stock options and selling shares, including shares withheld for taxes, on August 12, 2025.

Summary

• James P. Zallie, President and CEO, and a Director of Ingredion Inc (INGR), reported multiple transactions on August 12, 2025.
• Exercised 96,316 employee stock options at an exercise price of $91.85 per share, which vested in three equal annual installments from February 8, 2020, to February 8, 2022.
• Exercised 128,522 employee stock options at an exercise price of $88.35 per share, which vested in three equal annual installments from February 4, 2021, to February 4, 2023.
• Disposed of 81,634 shares at $126.46 per share, with 11,677.519 shares withheld for applicable taxes and the remainder for the exercise price of the stock options.
• Disposed of 106,917 shares at $126.54 per share, with 17,183.160 shares withheld for applicable taxes and the remainder for the exercise price of the stock options.
• Sold 36,287 shares at a weighted average price of $126.523 per share, with individual sales ranging from $126.50 to $126.60.
• Following these reported transactions, beneficial ownership of common stock was 50,128.895 shares, which includes restricted stock units (RSUs) acquired through deemed dividend reinvestment.
• An additional direct beneficial ownership of 73,530 common shares was reported.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions involving the exercise of stock options and subsequent sale of shares, including those withheld for taxes. This is a common event for executives managing their compensation and does not inherently indicate strong positive or negative sentiment about the company's future performance.

Positives

• The exercise of stock options indicates the executive's realization of value from previously granted equity compensation.
• The exercise prices ($91.85 and $88.35) are significantly lower than the sale prices (ranging from $126.46 to $126.54), indicating a profitable transaction for the insider.

Negatives

• A significant number of shares (36,287) were sold by a key executive, which could be perceived as a reduction in direct exposure to the company's stock.
• A large portion of the acquired shares (81,634 and 106,917) were immediately disposed of to cover taxes and exercise costs, limiting the net increase in direct ownership from the option exercises.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitors. It reflects individual executive compensation and stock management practices.

Comparison to Industry Standards

• This filing details a standard executive stock option exercise and subsequent sale, often done for liquidity or tax purposes. Such transactions are common across industries for executives managing their equity compensation.
• No specific comparable companies, projects, or results are mentioned in the filing to assess against.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive could be perceived as a slight negative, but the context of option exercise and tax withholding suggests it is a routine liquidity event rather than a lack of confidence. The net effect on total shares outstanding is minimal from this specific filing.
• Employees: No direct impact on employees is indicated.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.

Key Dates

Recommendation

This Form 4 details a routine insider transaction where the CEO exercised vested stock options and sold a portion of the shares, primarily to cover taxes and exercise costs, along with an additional sale. Such transactions are common for executive compensation and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation. The profitability of the option exercise for the insider is noted, but the overall transaction is neutral in terms of company performance implications.

Keywords

Ingredion, INGR, James P. Zallie, SEC Form 4, insider trading, stock options, share sale, executive compensation, beneficial ownership